查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1268574

水合物抑制剂的全球市场的预测(～2030年)

Hydrate Inhibitors Market Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 110 Pages | 订单完成后即时交付

价格

本报告提供全球水合物抑制剂市场相关调查分析，市场动态，地区和市场区隔的分析，企业简介等资讯。

目录

第1章 摘要整理

第2章 市场简介

第3章 调查手法

第4章 市场考察

第5章 市场动态

  • 简介
  • 促进因素
    • 石油、天然气产业的低用量水合物抑制剂的需求增加
    • 气体水合物的开采的进步
    • 促进因素的影响的分析
  • 阻碍因素
    • 抗凝集(AA)LDHI的使用相关的环境问题
    • 阻碍因素的影响的分析
  • 机会
    • 新兴经济各国的石油、天然气探勘活动的投资增加
    • 环保水合物抑制剂的研究开发
  • 课题
    • 高用量的热力学的抑制剂的必要性
    • 对水合物的形成控制的减压法的利用可能性
  • 趋势
    • 再生能源来源的转变
  • COVID-19影响的分析
    • 对产业整体的经济影响
    • 对生产的影响
    • 对水合物抑制剂产业的影响
    • 对供应链的影响
    • 对价格的影响
    • 对全球贸易的影响

第6章 市场要素的分析

  • 供应链分析
    • 原料的供应商
    • 水合物抑制剂生产者
    • 流通管道
    • 用途
  • 波特的五力分析
  • 价格分析 - 各地区(2021年)
  • 全球製造商市场集中率

第7章 全球水合物抑制剂市场:各类型

  • 简介
  • 热力学的抑制剂(THI)
  • 低用量水合物抑制剂(LDHI)

第8章 全球水合物抑制剂市场:各用途

  • 简介
  • 海上运用
  • 陆上运用

第9章 全球水合物抑制剂市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 挪威
    • 荷兰
    • 波兰
    • 丹麦
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲、纽西兰
    • 印尼
    • 韩国
    • 泰国
    • 其他的亚太地区
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美
  • 中东、非洲
    • GCC
    • 奈及利亚
    • 伊朗
    • 伊拉克
    • 埃及
    • 中东、非洲

第10章 竞争情形

  • 竞争概要
  • 全球市场策略的分析
  • 竞争基准
  • 竞争仪表板

第11章 企业简介

  • SCHLUMBERGER
  • BAKER HUGHES, A GE COMPANY LLC
  • BASF SE
  • HALLIBURTON

第12章 企业简介

  • HUNTSMAN INTERNATIONAL LLC
  • ASHLAND
  • ARKEMA
  • EVONIK INDUSTRIES AG
  • HUNTSMAN INTERNATIONAL LLC
  • ASHLAND
  • ARKEMA
  • EVONIK INDUSTRIES AG
  • ECOLAB
  • FINORIC LLC
  • OMNI INDUSTRIAL SOLUTIONS
  • TETRA TECHNOLOGIES, INC.

第13章 附录

Product Code: MRFR/CnM/7322-CR

Market Overview

Inhibitors of hydrate formation are chemicals used in the extraction of natural gas. Hydrate inhibitors help to avoid hydrate formation-related issues including hydrate plugs and line blockages and stop the development of gas hydrates under low temperature and high pressure situations. Thermodynamic hydrate inhibitors (THIs) and low dose hydrate inhibitors are the two categories of hydrate inhibitors (LDHIs). Contrary to what is necessary for thermodynamic inhibition, low dosage hydrate inhibitors help manage flow in pipelines by controlling the production of hydrates in a very small volume.

The global market for hydrate inhibitors is anticipated to develop during the research period due to the rising demand for low-dosage hydration inhibitors due to their performance qualities. The global hydrate inhibitor market is expanding as a result of the recent advances in gas hydrate drilling that have been made possible by the global decline in conventional oil and gas reserves. Furthermore, it is anticipated that throughout the projected period, players active in the worldwide hydrate inhibitors market will benefit from the rising investments in oil and gas exploration in developing nations.

Segment Overview

The market for Hydrate Inhibitors has been divided into three segments: type, application, and region. Thermodynamic inhibitors (THIs) and Low-dosage hydrate inhibitors (LDHIs) are the two type categories that make up the global Hydrate Inhibitors industry. The market has been divided into Onshore operations and Offshore operations based on application segment.

Regional Analysis

North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa are the five major regions covered in this study of the global market for hydrate inhibitors.

During the study period, the global market for hydrate inhibitors is anticipated to develop due to the rising demand for low-dosage hydration inhibitors due to their performance qualities. The world's conventional oil and gas reserves are being depleted, which is causing an increase in gas hydrate drilling technology, and this is helping the worldwide hydrate inhibitor market expand. The market expansion of hydrate inhibitors is being hindered by the high dose requirements of thermodynamic inhibitors and the availability of depressurization methods for managing hydrate formation. Additionally, the environmental problems related to the usage of anti-agglomerate (AA) LDHI are a hindrance to the expansion of the product market throughout the course of the projection period. Moreover, the global market for hydrate inhibitors is anticipated to see significant impetus during the projected period due to a shifting trend toward the usage and production of renewable sources of energy and renewable products.

Five geographical areas-North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa-are investigated in relation to the hydrate inhibitors market. In 2021, North America held the greatest market share among these regions.

Major Players

The main players in the market at the moment that are competing in terms of quality, price, and availability are Finoric LLC (US), Tetra Technologies, Inc. (US), BASF SE (Germany), a GE Company LLC (US), Halliburton (US), Ecolab (US), ARKEMA (France), Ashland (US), Huntsman International LLC (US), Evonik Industries AG (Germany), Schlumberger Limited (US), Omni Industrial Solutions (US), and Baker Hughes.

COVID 19 Impacts

Numerous markets have been negatively impacted by COVID-19, while other markets have benefited from its occurrence. The world continued to use fuel as usual even during the pandemic. The spread of a lethal virus and the global implementation of a complete lockdown had a minimal impact. Additionally, the value of hydrate inhibitors is influenced by the production of natural gas and crude oil. Since hydrate inhibitors are used in the production process, their use does not immediately affect the market for natural gas and crude oil products. Additionally, there is a huge global demand for fuel. Due to market players' need to close production facilities or run them at less than optimal production levels in order to stop the COVID-19 pandemic, the output of hydrate inhibitors decreased during this time. However, Tier 1 market participants have kept running their manufacturing plants.

The chemical distribution supply chain has been under intense pressure ever since the COVID-19 outbreak broke out. Ports in numerous nations experience severe congestion, which causes cargo ships to experience significant delays in unloading goods and, eventually, supplying items within a specific time frame. A small but lucrative segment of the worldwide chemical industry, the hydrate inhibitors market is intricately linked and dependent on steady supply.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 23

  • 1.1 MARKET ATTRACTIVENESS ANALYSIS 25
    • 1.1.1 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 26
    • 1.1.2 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 27
    • 1.1.3 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 28

2 MARKET INTRODUCTION 29

  • 2.1 DEFINITION 29
  • 2.2 SCOPE OF THE STUDY 29
  • 2.3 MARKET STRUCTURE 30

3 RESEARCH METHODOLOGY 31

  • 3.1 RESEARCH PROCESS 31
  • 3.2 PRIMARY RESEARCH 32
  • 3.3 SECONDARY RESEARCH 33
  • 3.4 MARKET SIZE ESTIMATION 34
  • 3.5 FORECAST MODEL 35
  • 3.6 LIST OF ASSUMPTIONS 36

4 MARKET INSIGHTS 37

5 MARKET DYNAMICS 42

  • 5.1 INTRODUCTION 42
  • 5.2 DRIVERS 43
    • 5.2.1 INCREASING DEMAND FOR LOW-DOSAGE HYDRATE INHIBITORS IN THE OIL & GAS INDUSTRY 43
    • 5.2.2 ADVANCEMENTS IN THE DRILLING OF GAS HYDRATES 43
    • 5.2.3 DRIVERS IMPACT ANALYSIS 44
  • 5.3 RESTRAINTS 44
    • 5.3.1 ENVIRONMENTAL ISSUES ASSOCIATED WITH THE USE OF ANTI-AGGLOMERATE (AA) LDHI 44
    • 5.3.2 RESTRAINTS IMPACT ANALYSIS 45
  • 5.4 OPPORTUNITIES 45
    • 5.4.1 INCREASING INVESTMENTS IN OIL & GAS EXPLORATION ACTIVITIES IN DEVELOPING ECONOMIES 45
    • 5.4.2 RESEARCH & DEVELOPMENT OF ECO-FRIENDLY HYDRATE INHIBITORS 46
  • 5.5 CHALLENGES 47
    • 5.5.1 REQUIREMENT OF HIGH DOSAGE OF THERMODYNAMIC INHIBITORS 47
    • 5.5.2 AVAILABILITY OF DEPRESSURIZATION METHOD FOR CONTROLLING HYDRATE FORMATION 47
  • 5.6 TRENDS 47
    • 5.6.1 SHIFT TOWARD RENEWABLE SOURCES OF ENERGY 47
  • 5.7 COVID 19 IMPACT ANALYSIS 48
    • 5.7.1 ECONOMIC IMPACT ON THE OVERALL INDUSTRY 48
    • 5.7.2 IMPACT ON PRODUCTION 48
    • 5.7.3 IMPACT ON HYDRATE INHIBITORS INDUSTRY 48
    • 5.7.4 IMPACT ON SUPPLY CHAIN 48
      • 5.7.4.1 IMPACT ON RAW MATERIALS 49
      • 5.7.4.2 PRICE VARIATIONS OF KEY RAW MATERIALS/COMPONENTS 49
      • 5.7.4.3 CASH FLOW CONSTRAINTS 49
    • 5.7.5 IMPACT ON PRICING 49
    • 5.7.6 IMPACT ON WORLD TRADE 49

6 MARKET FACTOR ANALYSIS 50

  • 6.1 SUPPLY CHAIN ANALYSIS 50
    • 6.1.1 RAW MATERIALS SUPPLIERS 51
      • 6.1.1.1 RAW MATERIAL SUPPLIERS FOR THERMODYNAMIC INHIBITORS (THIS) 51
      • 6.1.1.2 RAW MATERIAL SUPPLIERS FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHIS) 51
    • 6.1.2 HYDRATE INHIBITOR PRODUCERS 51
    • 6.1.3 DISTRIBUTION CHANNEL 52
    • 6.1.4 APPLICATIONS 52
  • 6.2 PORTER'S FIVE FORCES MODEL 53
    • 6.2.1 THREAT OF NEW ENTRANTS 53
    • 6.2.2 THREAT OF SUBSTITUTES 54
    • 6.2.3 BARGAINING POWER OF SUPPLIERS 54
    • 6.2.4 BARGAINING POWER OF BUYERS 54
    • 6.2.5 INTENSITY OF COMPETITIVE RIVALRY 54
  • 6.3 PRICING ANALYSIS - BY REGION (USD/TON), 2021 55
  • 6.4 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO 55

7 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 56

  • 7.1 INTRODUCTION 56
  • 7.2 THERMODYNAMIC INHIBITORS (THI) 58
  • 7.3 LOW-DOSAGE HYDRATE INHIBITORS (LDHI) 60

8 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 62

  • 8.1 INTRODUCTION 62
  • 8.2 OFFSHORE OPERATIONS 64
  • 8.3 ONSHORE OPERATIONS 65

9 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 66

  • 9.1 OVERVIEW 66
  • 9.2 NORTH AMERICA 70
    • 9.2.1 US 74
    • 9.2.2 CANADA 78
  • 9.3 EUROPE 82
    • 9.3.1 GERMANY 87
    • 9.3.2 UK 91
    • 9.3.3 FRANCE 95
    • 9.3.4 ITALY 99
    • 9.3.5 RUSSIA 103
    • 9.3.6 NORWAY 107
    • 9.3.7 NETHERLANDS 111
    • 9.3.8 POLAND 115
    • 9.3.9 DENMARK 119
    • 9.3.10 REST OF EUROPE 123
  • 9.4 ASIA-PACIFIC 127
    • 9.4.1 CHINA 132
    • 9.4.2 JAPAN 136
    • 9.4.3 INDIA 140
    • 9.4.4 AUSTRALIA & NEW ZEALAND 144
    • 9.4.5 INDONESIA 148
    • 9.4.6 SOUTH KOREA 152
    • 9.4.7 THAILAND 156
    • 9.4.8 REST OF ASIA-PACIFIC 160
  • 9.5 LATIN AMERICA 164
    • 9.5.1 BRAZIL 169
    • 9.5.2 MEXICO 173
    • 9.5.3 ARGENTINA 177
    • 9.5.4 REST OF LATIN AMERICA 181
  • 9.6 THE MIDDLE EAST AND AFRICA 185
    • 9.6.1 GCC 190
    • 9.6.2 NIGERIA 194
    • 9.6.3 IRAN 198
    • 9.6.4 IRAQ 202
    • 9.6.5 EGYPT 206
    • 9.6.6 REST OF THE MIDDLE EAST AND AFRICA 210

10 COMPETITIVE LANDSCAPE 214

  • 10.1 COMPETITIVE OVERVIEW 214
  • 10.2 GLOBAL MARKET STRATEGY ANALYSIS 214
  • 10.3 COMPETITIVE BENCHMARKING 215
  • 10.4 COMPETITION DASHBOARD 216

11 COMPANY PROFILES 217

  • 11.1 SCHLUMBERGER 217
    • 11.1.1 COMPANY OVERVIEW 217
    • 11.1.2 FINANCIAL OVERVIEW 218
    • 11.1.3 PRODUCT OFFERINGS 218
    • 11.1.4 KEY DEVELOPMENTS 218
    • 11.1.5 SWOT ANALYSIS 219
    • 11.1.6 KEY STRATEGIES 219
  • 11.2 BAKER HUGHES, A GE COMPANY LLC 220
    • 11.2.1 COMPANY OVERVIEW 220
    • 11.2.2 FINANCIAL OVERVIEW 221
    • 11.2.3 PRODUCT OFFERINGS 221
    • 11.2.4 KEY DEVELOPMENTS 222
    • 11.2.5 SWOT ANALYSIS 222
    • 11.2.6 KEY STRATEGIES 222
  • 11.3 BASF SE 223
    • 11.3.1 COMPANY OVERVIEW 223
    • 11.3.2 FINANCIAL OVERVIEW 224
    • 11.3.3 PRODUCT OFFERINGS 224
    • 11.3.4 KEY DEVELOPMENTS 225
    • 11.3.5 SWOT ANALYSIS 225
    • 11.3.6 KEY STRATEGIES 225
  • 11.4 HALLIBURTON 226
    • 11.4.1 COMPANY OVERVIEW 226
    • 11.4.2 FINANCIAL OVERVIEW 226
    • 11.4.3 PRODUCT OFFERINGS 227
    • 11.4.4 KEY DEVELOPMENTS 227
    • 11.4.5 SWOT ANALYSIS 227
    • 11.4.6 KEY STRATEGIES 227

12 COMPANY PROFILES 228

  • 12.1 HUNTSMAN INTERNATIONAL LLC 228
    • 12.1.1 COMPANY OVERVIEW 228
    • 12.1.2 FINANCIAL OVERVIEW 229
    • 12.1.3 PRODUCT OFFERINGS 229
    • 12.1.4 KEY DEVELOPMENTS 230
    • 12.1.5 SWOT ANALYSIS 230
    • 12.1.6 KEY STRATEGIES 230
  • 12.2 ASHLAND 231
    • 12.2.1 COMPANY OVERVIEW 231
    • 12.2.2 FINANCIAL OVERVIEW 232
    • 12.2.3 PRODUCT OFFERINGS 232
    • 12.2.4 KEY DEVELOPMENTS 233
    • 12.2.5 SWOT ANALYSIS 233
    • 12.2.6 KEY STRATEGIES 233
  • 12.3 ARKEMA 234
    • 12.3.1 COMPANY OVERVIEW 234
    • 12.3.2 FINANCIAL OVERVIEW 235
    • 12.3.3 PRODUCT OFFERINGS 235
    • 12.3.4 KEY DEVELOPMENTS 236
    • 12.3.5 SWOT ANALYSIS 236
    • 12.3.6 KEY STRATEGIES 236
  • 12.4 EVONIK INDUSTRIES AG 237
    • 12.4.1 COMPANY OVERVIEW 237
    • 12.4.2 FINANCIAL OVERVIEW 238
    • 12.4.3 PRODUCT OFFERINGS 238
    • 12.4.4 KEY DEVELOPMENTS 239
    • 12.4.5 SWOT ANALYSIS 239
    • 12.4.6 KEY STRATEGIES 239
  • 12.5 HUNTSMAN INTERNATIONAL LLC 240
    • 12.5.1 COMPANY OVERVIEW 240
    • 12.5.2 FINANCIAL OVERVIEW 241
    • 12.5.3 PRODUCT OFFERINGS 241
    • 12.5.4 KEY DEVELOPMENTS 242
    • 12.5.5 SWOT ANALYSIS 242
    • 12.5.6 KEY STRATEGIES 242
  • 12.6 ASHLAND 243
    • 12.6.1 COMPANY OVERVIEW 243
    • 12.6.2 FINANCIAL OVERVIEW 244
    • 12.6.3 PRODUCT OFFERINGS 244
    • 12.6.4 KEY DEVELOPMENTS 245
    • 12.6.5 SWOT ANALYSIS 245
    • 12.6.6 KEY STRATEGIES 245
  • 12.7 ARKEMA 246
    • 12.7.1 COMPANY OVERVIEW 246
    • 12.7.2 FINANCIAL OVERVIEW 247
    • 12.7.3 PRODUCT OFFERINGS 247
    • 12.7.4 KEY DEVELOPMENTS 248
    • 12.7.5 SWOT ANALYSIS 248
    • 12.7.6 KEY STRATEGIES 248
  • 12.8 EVONIK INDUSTRIES AG 249
    • 12.8.1 COMPANY OVERVIEW 249
    • 12.8.2 FINANCIAL OVERVIEW 250
    • 12.8.3 PRODUCT OFFERINGS 250
    • 12.8.4 KEY DEVELOPMENTS 251
    • 12.8.5 SWOT ANALYSIS 251
    • 12.8.6 KEY STRATEGIES 251
  • 12.9 ECOLAB 252
    • 12.9.1 COMPANY OVERVIEW 252
    • 12.9.2 FINANCIAL OVERVIEW 253
    • 12.9.3 PRODUCTS OFFERED 253
    • 12.9.4 KEY DEVELOPMENTS 254
    • 12.9.5 SWOT ANALYSIS 254
    • 12.9.6 KEY STRATEGIES 254
  • 12.10 FINORIC LLC 255
    • 12.10.1 COMPANY OVERVIEW 255
    • 12.10.2 FINANCIAL OVERVIEW 255
    • 12.10.3 PRODUCTS OFFERED 255
    • 12.10.4 KEY DEVELOPMENTS 255
    • 12.10.5 SWOT ANALYSIS 256
    • 12.10.6 KEY STRATEGIES 256
  • 12.11 OMNI INDUSTRIAL SOLUTIONS 257
    • 12.11.1 COMPANY OVERVIEW 257
    • 12.11.2 FINANCIAL OVERVIEW 257
    • 12.11.3 PRODUCTS OFFERED 257
    • 12.11.4 KEY DEVELOPMENTS 257
    • 12.11.5 SWOT ANALYSIS 258
    • 12.11.6 KEY STRATEGIES 258
  • 12.12 TETRA TECHNOLOGIES, INC. 259
    • 12.12.1 COMPANY OVERVIEW 259
    • 12.12.2 FINANCIAL OVERVIEW 260
    • 12.12.3 PRODUCTS OFFERED 260
    • 12.12.4 KEY DEVELOPMENTS 261
    • 12.12.5 SWOT ANALYSIS 261
    • 12.12.6 KEY STRATEGIES 261

13 APPENDIX 262

  • 13.1 REFERENCES 262
  • 13.2 RELATED REPORTS 263

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 36
  • TABLE 2 MANUFACTURERS MARKET CONCENTRATION RATIO, BY REGION 55
  • TABLE 3 GLOBAL HYDRATE INHIBITORS, BY TYPE, 2019-2030 (USD THOUSAND) 56
  • TABLE 4 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 57
  • TABLE 5 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 58
  • TABLE 6 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 58
  • TABLE 7 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2019-2030 (USD THOUSAND) 59
  • TABLE 8 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2019-2030 (TONS) 59
  • TABLE 9 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 60
  • TABLE 10 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 60
  • TABLE 11 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2019-2030 (USD THOUSAND) 61
  • TABLE 12 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2019-2030 (TONS) 61
  • TABLE 13 GLOBAL HYDRATE INHIBITORS, BY APPLICATION, 2019-2030 (USD THOUSAND) 62
  • TABLE 14 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 63
  • TABLE 15 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2019-2030 (USD THOUSAND) 64
  • TABLE 16 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2019-2030 (TONS) 64
  • TABLE 17 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2019-2030 (USD THOUSAND) 65
  • TABLE 18 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2019-2030 (TONS) 65
  • TABLE 19 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2022-2030(USD THOUSAND) 67
  • TABLE 20 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2022-2030(TONS) 68
  • TABLE 21 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2022-2030(USD THOUSAND) 69
  • TABLE 22 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2022-2030(TONS) 69
  • TABLE 23 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2022-2030(USD THOUSAND) 69
  • TABLE 24 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2022-2030(TONS) 69
  • TABLE 25 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND) 70
  • TABLE 26 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (TONS) 70
  • TABLE 27 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 70
  • TABLE 28 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 70
  • TABLE 29 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 71
  • TABLE 30 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 71
  • TABLE 31 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 72
  • TABLE 32 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 72
  • TABLE 33 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 73
  • TABLE 34 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 73
  • TABLE 35 US HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 74
  • TABLE 36 US HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 74
  • TABLE 37 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 75
  • TABLE 38 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 75
  • TABLE 39 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 76
  • TABLE 40 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 76
  • TABLE 41 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 77
  • TABLE 42 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 77
  • TABLE 43 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 78
  • TABLE 44 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 78
  • TABLE 45 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 79
  • TABLE 46 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 79
  • TABLE 47 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 80
  • TABLE 48 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 80
  • TABLE 49 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 81
  • TABLE 50 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 81
  • TABLE 51 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND) 82
  • TABLE 52 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (TONS) 82
  • TABLE 53 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 83
  • TABLE 54 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 83
  • TABLE 55 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 84
  • TABLE 56 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 84
  • TABLE 57 EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 85
  • TABLE 58 EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 85
  • TABLE 59 EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 86
  • TABLE 60 EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 86
  • TABLE 61 GERMANY HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 87
  • TABLE 62 GERMANY HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 87
  • TABLE 63 GERMANY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 88
  • TABLE 64 GERMANY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 88
  • TABLE 65 GERMANY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 89
  • TABLE 66 GERMANY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 89
  • TABLE 67 GERMANY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 90
  • TABLE 68 GERMANY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 90
  • TABLE 69 UK HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 91
  • TABLE 70 UK HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 91
  • TABLE 71 UK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 92
  • TABLE 72 UK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 92
  • TABLE 73 UK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 93
  • TABLE 74 UK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 93
  • TABLE 75 UK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 94
  • TABLE 76 UK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 94
  • TABLE 77 FRANCE HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 95
  • TABLE 78 FRANCE HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 95
  • TABLE 79 FRANCE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 96
  • TABLE 80 FRANCE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 96
  • TABLE 81 FRANCE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 97
  • TABLE 82 FRANCE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 97
  • TABLE 83 FRANCE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 98
  • TABLE 84 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 98
  • TABLE 85 ITALY HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 99
  • TABLE 86 ITALY HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 99
  • TABLE 87 ITALY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 100
  • TABLE 88 ITALY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 100
  • TABLE 89 ITALY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 101
  • TABLE 90 ITALY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 101
  • TABLE 91 ITALY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 102
  • TABLE 92 ITALY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 102
  • TABLE 93 RUSSIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 103
  • TABLE 94 RUSSIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 103
  • TABLE 95 RUSSIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 104
  • TABLE 96 RUSSIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 104
  • TABLE 97 RUSSIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 105
  • TABLE 98 RUSSIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 105
  • TABLE 99 RUSSIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 106
  • TABLE 100 RUSSIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 106
  • TABLE 101 NORWAY HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 107
  • TABLE 102 NORWAY HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 107
  • TABLE 103 NORWAY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 108
  • TABLE 104 NORWAY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 108
  • TABLE 105 NORWAY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 109
  • TABLE 106 NORWAY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 109
  • TABLE 107 NORWAY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 110
  • TABLE 108 NORWAY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 110
  • TABLE 109 NETHERLANDS HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 111
  • TABLE 110 NETHERLANDS HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 111
  • TABLE 111 NETHERLANDS HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 112
  • TABLE 112 NETHERLANDS HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 112
  • TABLE 113 NETHERLANDS HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 113
  • TABLE 114 NETHERLANDS HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 113
  • TABLE 115 NETHERLANDS HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 114
  • TABLE 116 NETHERLANDS HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 114
  • TABLE 117 POLAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 115
  • TABLE 118 POLAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 115
  • TABLE 119 POLAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 116
  • TABLE 120 POLAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 116
  • TABLE 121 POLAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 117
  • TABLE 122 POLAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 117
  • TABLE 123 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 118
  • TABLE 124 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 118
  • TABLE 125 DENMARK HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 119
  • TABLE 126 DENMARK HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 119
  • TABLE 127 DENMARK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 120
  • TABLE 128 DENMARK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 120
  • TABLE 129 DENMARK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 121
  • TABLE 130 DENMARK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 121
  • TABLE 131 DENMARK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 122
  • TABLE 132 DENMARK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 122
  • TABLE 133 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 123
  • TABLE 134 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 123
  • TABLE 135 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 124
  • TABLE 136 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 124
  • TABLE 137 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 125
  • TABLE 138 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 125
  • TABLE 139 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 126
  • TABLE 140 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 126
  • TABLE 141 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND) 127
  • TABLE 142 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (TONS) 127
  • TABLE 143 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 128
  • TABLE 144 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 128
  • TABLE 145 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 129
  • TABLE 146 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 129
  • TABLE 147 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 130
  • TABLE 148 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 130
  • TABLE 149 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 131
  • TABLE 150 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 131
  • TABLE 151 CHINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 132
  • TABLE 152 CHINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 132
  • TABLE 153 CHINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 133
  • TABLE 154 CHINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 133
  • TABLE 155 CHINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 134
  • TABLE 156 CHINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 134
  • TABLE 157 CHINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 135
  • TABLE 158 CHINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 135
  • TABLE 159 JAPAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 136
  • TABLE 160 JAPAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 136
  • TABLE 161 JAPAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 137
  • TABLE 162 JAPAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 137
  • TABLE 163 JAPAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 138
  • TABLE 164 JAPAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 138
  • TABLE 165 JAPAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 139
  • TABLE 166 JAPAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 139
  • TABLE 167 INDIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 140
  • TABLE 168 INDIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 140
  • TABLE 169 INDIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 141
  • TABLE 170 INDIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 141
  • TABLE 171 INDIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 142
  • TABLE 172 INDIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 142
  • TABLE 173 INDIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 143
  • TABLE 174 INDIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 143
  • TABLE 175 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 144
  • TABLE 176 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 144
  • TABLE 177 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 145
  • TABLE 178 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 145
  • TABLE 179 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 146
  • TABLE 180 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 146
  • TABLE 181 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 147
  • TABLE 182 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 147
  • TABLE 183 INDONESIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 148
  • TABLE 184 INDONESIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 148
  • TABLE 185 INDONESIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 149
  • TABLE 186 INDONESIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 149
  • TABLE 187 INDONESIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 150
  • TABLE 188 INDONESIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 150
  • TABLE 189 INDONESIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 151
  • TABLE 190 INDONESIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 151
  • TABLE 191 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 152
  • TABLE 192 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 152
  • TABLE 193 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 153
  • TABLE 194 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 153
  • TABLE 195 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 154
  • TABLE 196 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 154
  • TABLE 197 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 155
  • TABLE 198 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 155
  • TABLE 199 THAILAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 156
  • TABLE 200 THAILAND HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 156
  • TABLE 201 THAILAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 157
  • TABLE 202 THAILAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 157
  • TABLE 203 THAILAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 158
  • TABLE 204 THAILAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 158
  • TABLE 205 THAILAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 159
  • TABLE 206 THAILAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 159
  • TABLE 207 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 160
  • TABLE 208 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 160
  • TABLE 209 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 161
  • TABLE 210 REST OF HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 161
  • TABLE 211 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 162
  • TABLE 212 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 162
  • TABLE 213 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 163
  • TABLE 214 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 163
  • TABLE 215 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND) 164
  • TABLE 216 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (TONS) 164
  • TABLE 217 LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 165
  • TABLE 218 LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 165
  • TABLE 219 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 166
  • TABLE 220 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 166
  • TABLE 221 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 167
  • TABLE 222 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 167
  • TABLE 223 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 168
  • TABLE 224 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 168
  • TABLE 225 BRAZIL HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 169
  • TABLE 226 BRAZIL HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 169
  • TABLE 227 BRAZIL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 170
  • TABLE 228 BRAZIL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 170
  • TABLE 229 BRAZIL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 171
  • TABLE 230 BRAZIL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 171
  • TABLE 231 BRAZIL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 172
  • TABLE 232 BRAZIL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 172
  • TABLE 233 MEXICO HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 173
  • TABLE 234 MEXICO HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 173
  • TABLE 235 MEXICO HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 174
  • TABLE 236 MEXICO HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 174
  • TABLE 237 MEXICO HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 175
  • TABLE 238 MEXICO HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 175
  • TABLE 239 MEXICO HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 176
  • TABLE 240 MEXICO HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 176
  • TABLE 241 ARGENTINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 177
  • TABLE 242 ARGENTINA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 177
  • TABLE 243 ARGENTINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 178
  • TABLE 244 ARGENTINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 178
  • TABLE 245 ARGENTINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 179
  • TABLE 246 ARGENTINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 179
  • TABLE 247 ARGENTINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 180
  • TABLE 248 ARGENTINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 180
  • TABLE 249 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 181
  • TABLE 250 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 181
  • TABLE 251 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 182
  • TABLE 252 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 182
  • TABLE 253 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 183
  • TABLE 254 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (TONS) 183
  • TABLE 255 REST OF LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 184
  • TABLE 256 REST OF LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 184
  • TABLE 257 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND) 185
  • TABLE 258 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019-2030(TONS) 185
  • TABLE 259 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 186
  • TABLE 260 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 186
  • TABLE 261 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 187
  • TABLE 262 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 187
  • TABLE 263 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 188
  • TABLE 264 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 188
  • TABLE 265 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 189
  • TABLE 266 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 189
  • TABLE 267 GCC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 190
  • TABLE 268 GCC HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 190
  • TABLE 269 GCC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 191
  • TABLE 270 GCC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 191
  • TABLE 271 GCC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 192
  • TABLE 272 GCC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 192
  • TABLE 273 GCC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 193
  • TABLE 274 GCC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 193
  • TABLE 275 NIGERIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 194
  • TABLE 276 NIGERIA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 194
  • TABLE 277 NIGERIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (USD THOUSAND) 195
  • TABLE 278 NIGERIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030 (TONS) 195
  • TABLE 279 NIGERIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 196
  • TABLE 280 NIGERIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 196
  • TABLE 281 NIGERIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 197
  • TABLE 282 NIGERIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 197
  • TABLE 283 IRAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 198
  • TABLE 284 IRAN HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 198
  • TABLE 285 IRAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 199
  • TABLE 286 IRAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 199
  • TABLE 287 IRAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 200
  • TABLE 288 IRAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 200
  • TABLE 289 IRAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 201
  • TABLE 290 IRAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 201
  • TABLE 291 IRAQ HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 202
  • TABLE 292 IRAQ HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 202
  • TABLE 293 IRAQ HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 203
  • TABLE 294 IRAQ HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 203
  • TABLE 295 IRAQ HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 204
  • TABLE 296 IRAQ HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 204
  • TABLE 297 IRAQ HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 205
  • TABLE 298 IRAQ HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 205
  • TABLE 299 EGYPT HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(USD THOUSAND) 206
  • TABLE 300 EGYPT HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 206
  • TABLE 301 EGYPT HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 207
  • TABLE 302 EGYPT HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 207
  • TABLE 303 EGYPT HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030 (USD THOUSAND) 208
  • TABLE 304 EGYPT HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 208
  • TABLE 305 EGYPT HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 209
  • TABLE 306 EGYPT HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 209
  • TABLE 307 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 210
  • TABLE 308 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030(TONS) 210
  • TABLE 309 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(USD THOUSAND) 211
  • TABLE 310 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019-2030(TONS) 211
  • TABLE 311 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(USD THOUSAND) 212
  • TABLE 312 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019-2030(TONS) 212
  • TABLE 313 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(USD THOUSAND) 213
  • TABLE 314 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030(TONS) 213
  • TABLE 315 COMPETITION DASHBOARD 216
  • TABLE 316 SCHLUMBERGER: PRODUCT OFFERINGS 218
  • TABLE 317 BAKER HUGHES, A GE COMPANY LLC: PRODUCT OFFERINGS 221
  • TABLE 318 BASF SE: PRODUCT OFFERINGS 224
  • TABLE 319 HALLIBURTON: PRODUCT OFFERINGS 227
  • TABLE 320 HUNTSMAN INTERNATIONAL LLC: PRODUCT OFFERINGS 229
  • TABLE 321 ASHLAND: PRODUCT OFFERINGS 232
  • TABLE 322 PRODUCT OFFERINGS 235
  • TABLE 323 EVONIK INDUSTRIES AG: PRODUCT OFFERINGS 238
  • TABLE 324 HUNTSMAN INTERNATIONAL LLC: PRODUCT OFFERINGS 241
  • TABLE 325 ASHLAND: PRODUCT OFFERINGS 244
  • TABLE 326 PRODUCT OFFERINGS 247
  • TABLE 327 EVONIK INDUSTRIES AG: PRODUCT OFFERINGS 250
  • TABLE 328 ECOLAB: PRODUCTS OFFERED 253
  • TABLE 329 FINORIC LLC: PRODUCTS OFFERED 255
  • TABLE 330 OMNI INDUSTRIAL SOLUTIONS: PRODUCTS OFFERED 257
  • TABLE 331 TETRA TECHNOLOGIES, INC: PRODUCTS OFFERED 260

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 24
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL HYDRATE INHIBITORS MARKET 25
  • FIGURE 3 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY TYPE 26
  • FIGURE 4 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY APPLICATION 27
  • FIGURE 5 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY REGION 28
  • FIGURE 6 GLOBAL HYDRATE INHIBITORS MARKET: STRUCTURE 30
  • FIGURE 7 RESEARCH PROCESS 31
  • FIGURE 8 TOP-DOWN & BOTTOM-UP APPROACHES 34
  • FIGURE 9 NORTH AMERICA MARKET SHARE BY COUNTRY (2021 VS 2030) 37
  • FIGURE 10 EUROPE MARKET SHARE BY COUNTRY (2021 VS 2030) 38
  • FIGURE 11 ASIA-PACIFIC MARKET SHARE BY COUNTRY (2021 VS 2030) 39
  • FIGURE 12 LATIN AMERICA MARKET SHARE BY COUNTRY (2021 VS 2030) 40
  • FIGURE 13 MIDDLE EAST & AFRICA MARKET SHARE BY COUNTRY (2021 VS 2030) 41
  • FIGURE 14 MARKET DYNAMICS OF GLOBAL HYDRATE INHIBITORS MARKET 42
  • FIGURE 15 DRIVERS IMPACT ANALYSIS: LOW DOSAGE HYDRATE INHIBITORS MARKET 44
  • FIGURE 16 RESTRAINTS IMPACT ANALYSIS: GLOBAL HYDRATE INHIBITORS MARKET 45
  • FIGURE 17 SUPPLY CHAIN: GLOBAL HYDRATE INHIBITORS MARKET 50
  • FIGURE 18 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL HYDRATE INHIBITORS MARKET 53
  • FIGURE 19 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (USD THOUSAND) 56
  • FIGURE 20 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019-2030 (TONS) 57
  • FIGURE 21 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (USD THOUSAND) 62
  • FIGURE 22 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019-2030 (TONS) 63
  • FIGURE 23 GLOBAL HYDRATE INHIBITORS MARKET BY REGION, 2022-2030(USD THOUSAND) 67
  • FIGURE 24 GLOBAL HYDRATE INHIBITORS MARKET BY REGION, 2022-2030(TONS) 68
  • FIGURE 25 SCHLUMBERGER: FINANCIAL OVERVIEW SNAPSHOT 218
  • FIGURE 26 SCHLUMBERGER: SWOT ANALYSIS 219
  • FIGURE 27 BAKER HUGHES, A GE COMPANY LLC: FINANCIAL OVERVIEW SNAPSHOT 221
  • FIGURE 28 BAKER HUGHES, A GE COMPANY LLC: SWOT ANALYSIS 222
  • FIGURE 29 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 224
  • FIGURE 30 BASF SE: SWOT ANALYSIS 225
  • FIGURE 31 HALLIBURTON: FINANCIAL OVERVIEW SNAPSHOT 226
  • FIGURE 32 HALLIBURTON: SWOT ANALYSIS 227
  • FIGURE 33 HUNTSMAN INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT 229
  • FIGURE 34 HUNTSMAN INTERNATIONAL LLC: SWOT ANALYSIS 230
  • FIGURE 35 ASHLAND: FINANCIAL OVERVIEW SNAPSHOT 232
  • FIGURE 36 ASHLAND: SWOT ANALYSIS 233
  • FIGURE 37 FINANCIAL OVERVIEW SNAPSHOT 235
  • FIGURE 38 SWOT ANALYSIS 236
  • FIGURE 39 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT 238
  • FIGURE 40 SWOT ANALYSIS 239
  • FIGURE 41 HUNTSMAN INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT 241
  • FIGURE 42 HUNTSMAN INTERNATIONAL LLC: SWOT ANALYSIS 242
  • FIGURE 43 ASHLAND: FINANCIAL OVERVIEW SNAPSHOT 244
  • FIGURE 44 ASHLAND: SWOT ANALYSIS 245
  • FIGURE 45 FINANCIAL OVERVIEW SNAPSHOT 247
  • FIGURE 46 SWOT ANALYSIS 248
  • FIGURE 47 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT 250
  • FIGURE 48 SWOT ANALYSIS 251
  • FIGURE 49 ECOLAB: FINANCIAL OVERVIEW SNAPSH 253
  • FIGURE 50 ECOLAB: SWOT ANALYSIS 254
  • FIGURE 51 FINORIC LLC: SWOT ANALYSIS 256
  • FIGURE 52 OMNI INDUSTRIAL SOLUTIONS: SWOT ANALYSIS 258
  • FIGURE 53 TETRA TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT 260
  • FIGURE 54 TETRA TECHNOLOGIES, INC: SWOT ANALYSIS 261 LIST OF ABBREVIATION Abbreviation Full Form US United States UK United Kingdom ME&A Middle East & Africa RoW Rest Of The World CAGR Compound Annual Growth Rate